NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









iXLife Capital

iXLife Capital

Marly-le-Roiixlife.com

Overview

iXLife Capital is a venture capital firm based in France that specializes in early-stage biotechnology and life sciences investments, focusing on innovative therapies for oncology, neurology, and rare diseases.

Year Founded

2010

Portfolio Companies

3

Website

ixlife.com

Investments

iXLife Capital investments
CompanyDateStageLead
SeaBeLifeOct 2025Early FundingLead
SeaBeLifeSep 2023SeedLead
ATANIS Biotech AGMar 2023Early FundingLead
PharmaleadsOct 2014VC RoundCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersMarly-le-Roi
Year Founded2010

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.